Search - tctmd.com

Displaying 21 - 35 of 35

Sort: Relevancy | Date

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

L.A. McKeown

December 18, 2018

News Industry News

Veryan Medical receives PMA approval for BioMimics 3D

October 05, 2018

News Conference News TCT 2018

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

Todd Neale

September 22, 2018

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

News Daily News

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

L.A. McKeown

October 18, 2017

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown

September 18, 2017

News Conference News VIVA 2017

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

L.A. McKeown

September 11, 2017

News Conference News ISET 2017

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Caitlin E. Cox

February 07, 2017

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Daily News

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

L.A. McKeown

December 20, 2016

News Conference News VIVA 2016

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

L.A. McKeown

September 20, 2016

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Daily News

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Salynn Boyles

December 15, 2014

News Daily News

Meta-analysis Looks at Bypass vs. Endovascular Therapy for Femoropopliteal Lesions

L.A. McKeown

December 12, 2012

News Conference News AHA 2012

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

Jason Kahn

November 06, 2012

Advertisement

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

Veryan Medical receives PMA approval for BioMimics 3D

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Meta-analysis Looks at Bypass vs. Endovascular Therapy for Femoropopliteal Lesions

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content